On the other hand, proinflammatory Th17 (Figure 3M) and IL17-producing CD4 + T cells (Figure 3N) were found to be significantly higher in AOM(FT) recipients compared to the other FT groups, and while AOM + Resveratrol(FT) recipients had decreased Th17 phenotype, this group was not able to decrease Th1 (CD4 + IFNγ+) cells. The gene discussed is IL17A; the disease is infectious otitis media.